超越血清素假说:重性抑郁障碍的神经可塑性框架
本文指出血清素缺乏假说证据不足,提出重性抑郁障碍可理解为认知与情绪脑环路的僵化及持续负性偏向,有效治疗通过增强神经可塑性恢复突触、网络和行为功能,并给出面向公众沟通的用语与隐喻。
要点
- 血清素缺乏假说证据不足,不应作为MDD的唯一解释。
- MDD可理解为认知情绪脑环路僵化与持续负性偏向。
- 有效治疗通过增强神经可塑性恢复功能,包括血清素能干预。
核心结论
- 重性抑郁障碍应被理解为认知与情绪脑环路僵化及持续负性偏向,而非单纯血清素缺乏。
- 有效治疗通过增强神经可塑性恢复突触、网络和行为功能,促进适应性认知情绪加工。
研究设计与样本
- 本文为综述,整合精神病学与神经科学的临床和临床前研究证据。
主要发现
- MDD涉及认知和情绪脑环路的僵化,并伴随持续负性偏向。
- 有效治疗包括典型单胺能抗抑郁药、氯胺酮与致幻剂等新型抗抑郁药、心理治疗和神经调控技术。
- 这些治疗增强神经可塑性机制,包括通过血清素能干预,恢复突触、网络和行为功能。
临床怎么用
- 临床沟通中可向患者和公众说明MDD的神经可塑性框架,替代血清素缺乏假说。
- 框架涵盖传统抗抑郁药、新型抗抑郁药、心理治疗和神经调控等治疗方式。
- 文中提供面向普通或患者受众讨论MDD的实用语言和隐喻。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The serotonin deficit hypothesis explanation for major depressive disorder (MDD) has persisted among clinicians and the general public alike despite insufficient supporting evidence. To combat rising mental health crises and eroding public trust in science and medicine, researchers and clinicians must be able to communicate to patients and the public an updated framework of MDD: one that is (1) accessible to a general audience, (2) accurately integrates current evidence about the efficacy of conventional serotonergic antidepressants with broader and deeper understandings of pathophysiology and treatment, and (3) capable of accommodating new evidence. In this article, we summarize a framework for the pathophysiology and treatment of MDD that is informed by clinical and preclinical research in psychiatry and neuroscience. First, we discuss how MDD can be understood as inflexibility in cognitive and emotional brain circuits that involves a persistent negativity bias. Second, we discuss how effective treatments for MDD enhance mechanisms of neuroplasticity-including via serotonergic interventions-to restore synaptic, network, and behavioral function in ways that facilitate adaptive cognitive and emotional processing. These treatments include typical monoaminergic antidepressants, novel antidepressants like ketamine and psychedelics, and psychotherapy and neuromodulation techniques. At the end of the article, we discuss this framework from the perspective of effective science communication and provide useful language and metaphors for researchers, clinicians, and other professionals discussing MDD with a general or patient audience.
引用
- Page CE, Epperson CN, Novick AM, et al. Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Mol Psychiatry. 2024. PMID: 38816586. doi:10.1038/s41380-024-02625-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。